Several other research analysts have also recently commented on AFX. Hauck Aufhäuser Investment Banking set a €195.00 ($198.98) price target on shares of Carl Zeiss Meditec in a report on Tuesday, September 13th. UBS Group set a €170.00 ($173.47) price target on shares of Carl Zeiss Meditec in a report on Friday, August 5th. Finally, Deutsche Bank Aktiengesellschaft set a €156.00 ($159.18) target price on shares of Carl Zeiss Meditec in a report on Monday, August 8th.
Carl Zeiss Meditec Price Performance
Shares of AFX opened at €107.00 ($109.18) on Thursday. Carl Zeiss Meditec has a fifty-two week low of €104.55 ($106.68) and a fifty-two week high of €202.00 ($206.12). The firm’s 50 day moving average price is €129.94 and its 200 day moving average price is €127.78. The company has a market cap of $9.57 billion and a P/E ratio of 41.20. The company has a quick ratio of 2.62, a current ratio of 3.35 and a debt-to-equity ratio of 6.84.
About Carl Zeiss Meditec
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries.
- What Steelcase’s Earnings Say About the Return to the Office?
- The Institutions Hold On To Darden Restaurants International
- These 3 Big Dividend Payers Also Boast Strong Price Growth
- Is The Golden Age Of Homebuilding Already Over?
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.